Richard A. Graham, SVP, DEVELOPMENT at Theravance Biopharma, Inc. (TBPH), sold 30,172 shares at $8.79 ($265K) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $265k TBPH by SVP, DEVELOPMENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.79 | 15,086 | $133K | 50.0% |
| 2 | $8.79 | 15,086 | $133K | 50.0% |
| Total | $8.79 avg | 30,172 | $265K | 100% |
| Filing → |
| TBPH | SELL | 2023-09-18 | $25K | — | Filing → |
| TBPH | SELL | 2023-08-15 | $23K | — | Filing → |
| TBPH | SELL | 2023-07-18 | $23K | — | Filing → |